Patients Attitudes towards Generic Substitution of Oral Atypical Antipsychotics: A Questionnaire-Based Survey in a Hypothetical Pharmacy Setting

CNS Drugs

Volumn 23, Issue 8, 2009, Pages 693-701

  Roman, Beatriz ^a  

^a TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; GENERIC DRUG; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG PACKAGING; DRUG SUBSTITUTION; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACIST; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; STRUCTURED QUESTIONNAIRE; TABLET FORMULATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; ATTITUDE; DRUGS, GENERIC; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 67650475332     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/00023210-200923080-00006     Document Type: Article

References (22)

1. Rheinstein PH. Therapeutic inequivalence. Drug Saf 1990; 5 Suppl. 1: 114-9
2. Kluznik JC, Walbek NH, Farnsworth MG, et al. Clinical effects of a randomized switch of patient from Clorazil to generic clozapine. J Clin Psychiatry 2001; 62 Suppl. 5: 14-7
3. Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clin Ther 2004 May; 26 (5): 801-2
4. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25 (11): 2875-90
5. Argumosa A, Herranz JL. The clinical and economic impact of generic drugs in the treatment of epilepsy. Rev Neurol 2005 Jul 1-15; 41 (1): 45-9
6. European Agency for the Evaluation of Medicinal Products. Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98, 2001 Jul 26 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/qwp/140198enfin.pdf [Accessed 2009 Apr 2]
7. Davis JM, Andriukaitis S. The natural course of schizophrenia and effective maintenance drug treatment. J Clin Psychopharmacol 1986; 6 (1 Suppl.): 2-10S
8. Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry 2001; 50 (11): 898-911
9. Walburn J, Gray R, Gournay K, et al. Systematic review of patient and nurse attitudes to depot medication. Br J Psychiatry 2001; 179: 300-7
10. Jarboe KS. Treatment non-adherence: causes and potential solutions. J Am Psychiatr Nurses Assoc 2002; 8 (4): s18-25
11. Siegel SJ, Winey KI, Gur RE, et al. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology 2002 Jun; 26 (6): 817-23
12. Tattan TMG, Creed FH. Negative symptoms of schizophrenia and compliance with medication. Schizophr Bull 2001; 27 (1): 149-55
13. Kjonniksen I, Lindbaek M, Granas AG. Patients' experiences with and attitudes to generic substitution. Tidsskr Nor Laegeforen 2005 Jun 16; 125 (12): 1682-4
14. Changing to a generic drug [online]. Available from URL: http://www.bpac.org.nz/magazine/2007/march/changing.asp [Accessed 2009 Apr 2]
15. Mott D, Cline R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002; 40 (8): 662-74
16. Nuss P, Taylor D, De Hert M, et al. The generic alternative in schizophrenia: opportunity or threat? CNS Drugs 2004; 18: 769-75
17. KNMP. Handbook on drug substitution. Den Haag: KNMP Geneesmiddel Informatie Centrum, 2006
18. Ryan M, Ubach C. Testing for an experience endowment effect in health care. Appl Econ Lett 2003; 10: 407-10
19. Salkeld G, Ryan M, Short L. The veil of experience: do consumers prefer what they know best? Health Econ 2000; 9: 267-70
20. Roman B. The design of antipsychotic medication treatments: the patients' and psychiatrists' perspectives on the choice for an administration form. Tilburg: University of Tilburg, 2004
21. Hogan TP, Awad AG, Eastwood R. A self-report predictive of drug compliance in schizophrenia: reliability and discriminative validity. Psychol Med 1983; 13: 177-83
22. Locniskar A, Greenblatt DJ, Harmatz JS, et al. Bioinequivalence of a generic brand of diazepam. Biopharm Drug Dispos 1989 Nov-Dec; 10 (6): 597-605